Stefanie Friedrich

Solna, AB, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers.

Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers.

Journal: Cell
Published: January 23, 2025

Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial.

Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial.

Journal: Research square
Published: February 17, 2023

Copy number architectures define treatment-mediated selection of lethal prostate cancer clones.

Copy number architectures define treatment-mediated selection of lethal prostate cancer clones.

Journal: Nature communications
Published: June 02, 2022

Accumulation of copy number alterations and clinical progression across advanced prostate cancer.

Accumulation of copy number alterations and clinical progression across advanced prostate cancer.

Journal: Genome medicine
Published: January 13, 2022

Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones.

Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones.

Journal: Nature communications
Published: April 23, 2021

MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia.

MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia.

Journal: Cancer research
Published: January 07, 2021

Fusion transcript detection using spatial transcriptomics.

Fusion transcript detection using spatial transcriptomics.

Journal: BMC medical genomics
Published: November 22, 2019

MetaCNV - a consensus approach to infer accurate copy numbers from low coverage data.

MetaCNV - a consensus approach to infer accurate copy numbers from low coverage data.

Journal: BMC medical genomics
Published: September 25, 2019

Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity.

Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity.

Journal: Nature communications
Published: October 03, 2017
Showing 1-9 of 9

Last Updated: 09/26/2026